Non-invasive Prenatal Testing Market Outlook, Leading Manufacturers, Industry Analysis And Forecast

 Non-invasive Prenatal Testing Market Growth & Trends

The global non invasive prenatal testing market size is anticipated to reach USD 6.5 billion by 2028 registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. High adoption and demand for early non-invasive prenatal testing (NIPT) coupled with improvements in reimbursement scenario are among the factors driving the market.

The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues, such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, non-invasive, and safe. Furthermore, non-invasive fetal tests have a lower failure and false-positive rate, which has resulted in a considerable increase in uptake of non-invasive tests in the last few years.

The non-invasive prenatal testing market is highly saturated with the existing key players. Companies are forming partnerships and collaborations to maintain a stable position in the market. For instance, in August 2020, Eurofins Scientific announced an agreement with Noritsu Koki Co., Ltd. for the acquisition of GeneTech Inc., one of the pioneering NIPT developers in Japan. With this acquisition, Eurofins Scientific is set to strengthen its presence in the Japanese NIPT market.

Request a free sample copy or view report summary: Non-invasive Prenatal Testing Market Report

Non-invasive Prenatal Testing Market Report Highlights

• The 13-24 weeks gestation period segment accounted for the largest revenue share in 2020 owing to the presence of a maximum number of tests carried out in this phase of pregnancy
• NIPT for high- & average-risk pregnancy led the market owing to the presence of favorable payer reimbursement policies in this segment
• Next-Generation Sequencing(NGS) is estimated to be the largest as well as the fastest-growing technology segment from 2021 to 2028, as NGS is the most commonly used method for NIPT
• The diagnostic laboratories end-use segment held the largest revenue share in 2020 and will expand further at the fastest CAGR from 2021 to 2028 due to the rising number of diagnostic laboratories across the globe that offer NIPT
• Asia Pacific is expected to register the fastest year-on-year growth owing to the gradually increasing average maternal age and rising incidence of chromosomal aneuploidies
• One of the key trends followed by market participants includes licensing of the test to other labs and generating significant revenue by collecting royalty payments

Non-invasive Prenatal Testing Market Segmentation

Grand View Research has segmented the global non-invasive prenatal testing market on the basis of the gestation period, risk type, method, technology, product, end-use, and region:

NIPT Gestation Period Outlook (Revenue, USD Million, 2017 - 2028)

• 0-12 Weeks
• 13-24 Weeks
• 25-36 Weeks

NIPT Risk Type Outlook (Revenue, USD Million, 2017 - 2028)

• High & Average Risk
• Low Risk

NIPT Method Outlook (Revenue, USD Million, 2017 - 2028)

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA in Maternal Plasma Tests

NIPT Technology Outlook (Revenue, USD Million, 2017 - 2028)

• NGS
• Array Technology
• PCR
• Other Technologies

NIPT Product Outlook (Revenue, USD Million, 2017 - 2028)

• Consumables & Reagents
• Instruments

NIPT End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals & Clinics
• Diagnostic Laboratories

NIPT Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Non-invasive Prenatal Testing Market

• Genesis Genetics (CooperSurgical, Inc.)
• Natera, Inc.
• Centogene N.V.
• Illumina, Inc. (Verinata Health, Inc.)
• Eurofins LifeCodexx GmbH
• MedGenome Labs Ltd.
• Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
• Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
• Progenity, Inc.
• Qiagen
• Laboratory Corp. of America Holdings
• Quest Diagnostics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Craniomaxillofacial Devices Market Trends Regulations And Competitive Landscape Outlook to 2028

 Craniomaxillofacial Devices Market Growth & Trends

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growingpreferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Request a free sample copy or view report summary: Craniomaxillofacial Devices Market Report

Craniomaxillofacial Devices Market Report Highlights

• In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
• The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
• Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
• Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

Craniomaxillofacial Devices Market Segmentation

Grand View Research has segmented the global craniomaxillofacial devices market on the basis of product, material, application, and region:

CMF Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Cranial Flap Fixation
• CMF Distraction
• Temporomandibular Joint Replacement
• Thoracic Fixation
• Bone Graft Substitute
• CMF Plate & Screw Fixation

CMF Devices Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Bioabsorbable Material
• Ceramics

CMF Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Neurosurgery & ENT
• Orthognathic & Dental Surgery
• Plastic Surgery

CMF Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Craniomaxillofacial Devices Market

• DePuy Synthes (J&J)
• Stryker Corp.
• Medtronic plc
• Zimmer Biomet

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Urinary Catheters Market Precise Analysis on Business Overview, Product Scope And Ongoing Market Development

 Urinary Catheters Market Growth & Trends

The global urinary catheters market size is anticipated to reach USD 7.94 billion by 2028 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing number of patients suffering from Urinary Tract Infections (UTI) and blockages in the urethra are anticipated to boost the product demand. The advent of technologically advanced products is also expected to drive market growth. For instance, RIOCATH - a Reversal Inside Out Catheterization, developed by Riocath global in collaboration with IOCB Prague, reduces the chances of infections in the body.

The key application segments include Benign Prostate Hyperplasia (BPH) & prostate surgeries, Urinary Incontinence (UI), spinal cord injury, and others. Among these, UI is the largest application segment owing to the increasing prevalence of the disease. Factors such as surgery of the prostate gland, spinal cord injury, injury to the bladder nerves, blockage in the urine due to kidney stones, and blood clots in the urine can cause UI. However, the BPH & prostate surgeries application segment is estimated to register the fastest CAGR during the forecast years. Based on product types, the market is divided into intermittent, foley/indwelling, and external catheters. The intermittent catheters segment dominated the overall market in 2020. This can be attributed to the increasing number of patients suffering from various urinary disorders. 

Request a free sample copy or view report summary: Urinary Catheters Market Report

Urinary Catheters Market Report Highlights

• North America was the leading regional market with the highest revenue share in 2020 and is estimated to expand further at a steady CAGR from 2021 to 2028
• This growth can be attributed to the high incidence of targeted diseases, such as UI, bladder obstruction, urinary retention, Benign Prostate Hyperplasia (BPH), and bladder cancer, in the region
• The key players are introducing technologically advanced products to gain a competitive advantage in the industry
• For instance, Coloplast is planning to expand its SpeediCath product portfolio by launching the SpeediCath Navi, which is designed especially for the treatment of patients suffering from chronic urine retention

Urinary Catheters Market Segmentation

Grand View Research has segmented the global urinary catheters market on the basis of product, application, and region:

Urinary Catheters Product Outlook (Revenue, USD Million, 2016 - 2028)

• Intermittent
• Foley/Indwelling
• External

Urinary Catheters Application Outlook (Revenue, USD Million, 2016 - 2028)

• Benign Prostate Hyperplasia (BPH) & Prostate Surgeries
• Urinary Incontinence
• Spinal Cord Injury
• Others

Urinary Catheters Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China (Mainland)
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Urinary Catheters Market

• Hollister, Inc.
• Medtronic PLC
• Boston Scientific Corp.
• Becton Dickinson And Company (C.R. Bard, Inc.)
• Cook Medical
• Teleflex, Inc.
• Medline Industries, Inc.
• J and M Urinary Catheters LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tumor Ablation Market to Undertake Strapping Growth By 2028

 Tumor Ablation Market Growth & Trends

The global tumor ablation market size is estimated to reach USD 2.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. The increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market growth. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62.0% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.

Increasing inclination towards minimally invasive procedures owing to benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.

Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in the early cancer stages, thereby driving the market.

The rising demand for advanced medical technologies coupled with improving financing capabilities of healthcare facilities is expected to increase the demand for medical devices being used for the treatment of tumors, during the forecast period. For instance, Maimonides Medical Centre, New York announced the purchase of advanced High Intensity Focused Ultrasound (HIFU) ablation device (Focal One by EDAP TMS SA) in 2019, becoming the second hospital in the U.S. to be equipped with HIFU technology.

Request a free sample copy or view report summary: Tumor Ablation Market Report

Tumor Ablation Market Report Highlights

• Radiofrequency dominated the technology segment and accounted for the largest revenue share of 35.5% in 2020 owing to prominent application in solid tumor removal
• Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
• The lung cancer segment is anticipated to witness the fastest growth over the forecast period
• A sedentary lifestyle, increasing incidences of smoking, and rising air pollution are the factors contributing to the growing prevalence of lung cancer
• North America dominated the market owing to factors such as the increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Tumor Ablation Market Segmentation

Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Radiofrequency
• Microwave
• Cryoablation
• Irreversible Electroporation
• Other Ablation Technologies

Tumor Ablation Treatment Outlook (Revenue, USD Million, 2016 - 2028)

• Surgical ablation
  • Kidney Cancer
  • Liver Cancer
  • Breast cancer
  • Lung Cancer
  • Prostate Cancer
  • Other cancers
• Laparoscopic Ablation
  • Kidney Cancer
  • Liver Cancer
  • Breast cancer
  • Lung Cancer
  • Prostate Cancer
  • Other cancers
• Percutaneous Ablation
  • Kidney Cancer
  • Liver Cancer
  • Breast cancer
  • Lung Cancer
  • Prostate Cancer
  • Other cancers

Tumor Ablation Application Outlook (Revenue, USD Million, 2016 - 2028)

• Kidney Cancer
• Liver Cancer
• Breast cancer
• Lung Cancer
• Prostate Cancer
• Other cancers

Tumor Ablation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Netherland
  • Switzerland
  • Belgium
  • Hungary
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Taiwan
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel

List of Key Players of Tumor Ablation Market

• Galil Medical Inc.
• Misonix Inc.
• HealthTronics
• Mermaid Medical
• Theraclion
• Chongqing Haifu Medical Technology Co., Ltd.
• HS Hospital Service S.P.A
• EDAP TMS S.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Brain Implants Market to Reflect a Holistic Expansion During 2021 to 2028: Grand View Research Inc.

 Brain Implants Market Growth & Trends

The global brain implants market size is anticipated to reach USD 9.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.1% from 2021 to 2028. The rise in neurological disorders such as epilepsy, Parkinson’s disease, depression, and tremors as well as growing investments in R&D to develop cost-effective brain implants is attributing to the growth of the market.

Presence of large number of population base suffering from various neurological and physiological disorders and conditions is expected to boost the demand for the implants during the forecast period. For instance, rising prevalence of Parkinson’s disease is boosting the demand for the implants as it helps in improving the movement of the body and reduces the need for drugs. As per the Parkinson’s Foundation 2016 report, over 10 million people globally are living with PD. Thus, with the increasing cases of Parkinson’s disease, the need for the implants is anticipated to grow lucratively.

In addition, technological advancement such as self-charging brain implants and memory chips is anticipated to provide the market with growth opportunities over the forecast period. For instance, in January 2020, Abbott’s Infinity DBS received an extended indication approval from the U.S. FDA for PD treatment.

Request a free sample copy or view report summary: Brain Implants Market Report

Brain Implants Market Report Highlights

• On the basis of product type, the deep brain stimulator segment dominated the market in 2020 and accounted for the largest revenue share of 37.0% owing to rising geriatric population prone to neurological diseases coupled with growing investments in development of the stimulators
• Based on application, the chronic pain segment dominated the market in 2020 with the share of 58.8% due to increasing prevalence of chronic pain disorders such as migraine, leg pain, and disk surgery pain. According to Migraine Research Foundation 2020, Migraine is the 3rd most prevalent neurological illness across the world, affecting 1.0 billion worldwide
• North America dominated the market with the highest revenue share of 42.9% in 2020. This is due high prevalence of psychological disorders, availability of highly skilled physicians, and rise in awareness about treatments in this continent
• Asia Pacific is expected to significantly lead the market in the future from 2021 to 2028 owing to increasing affordability and rising number of awareness programs about benefits of the implant

Brain Implants Market Segmentation

Grand View Research has segmented the global brain implants market on the basis of product, application, and region:

Brain Implants Product Outlook (Revenue, USD Million, 2016 - 2028)

• Deep Brain Stimulator
• Spinal Cord Stimulator
• Vagus Nerve Stimulator

Brain Implants Application Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic Pain
• Epilepsy
• Parkinson’s Disease
• Depression
• Essential Tremor
• Alzheimer’s Disease

Brain Implants Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Brain Implants Market

• Medtronic
• Boston Scientific Corporation
• Jude Medical (Abbott)
• NeuroPace, Inc.
• Nevro Corporation
• Synapse Biomedical Inc.
• Aleva Neurotherapeutics SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Regulatory Affairs Outsourcing Market Size Is Expected To Reach USD 14.9 Billion by 2028

 Regulatory Affairs Outsourcing Market Growth & Trends

The global regulatory affairs outsourcing market size is expected to reach USD 14.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.9% from 2021 to 2028. A significant increase in the fixed costs of in-house resources for regulatory affairs and operation activities, like training, technology, specialized knowledge, and facilities, is driving the outsourcing of regulatory affairs functions.

Addressing local regulatory challenges and constant changes in the regulations of the major markets, such as the U.S., Europe, and Asia, are creating demand for the services. Compliance with the current regulations has become an immense chore, leave alone trying to stay up to date with developments around the world. Amendments to current regulations are likely to simplify the regulatory pathway for the industry but, in turn, complicate the operation for healthcare product manufacturing companies. Thus, leading to the regulatory affairs outsourcing to service providers.

Moreover, due to the COVID-19, various healthcare companies are likely to opt for more regulatory advice in the recovery phase – on remote monitoring, telemedicine, data privacy, and more. Furthermore, as companies push to speed up the product development and approvals in therapies, vaccines, and devices for COVID-19, they are likely to engage even more intensively with the regulatory agencies.

Request a free sample copy or view report summary: Regulatory Affairs Outsourcing Market Report

Regulatory Affairs Outsourcing Market Report Highlights

• The regulatory writing and publishing services dominated the market with a share of 36.7% in 2020 as they are offered from the early stages of development to the post-marketing authorization phase and are vital for the success of a product
• In terms of company size, the large size companies are projected to expand at the fastest CAGR of 12.3% during the forecast period. Goodwill and resource abundance are the two key factors promoting their selection by end users
• By stage, the clinical segment accounted for the largest share of 46.7% in 2020 due to the increasing demand for clinical trials in developing countries
• Based on end user, the pharmaceutical companies are anticipated to register the fastest growth rate over the forecast period. This may be due to evolving areas such as orphan drugs and adaptive trial designs
• The Asia Pacific held the largest share of 37.9% in 2020 owing to higher offshoring of such services into regions of economic benefits and the expansion of life sciences companies in countries, such as India and China

Regulatory Affairs Outsourcing Market Segmentation

Grand View Research has segmented the global regulatory affairs outsourcing market based on service, company size, category, indication, stage, end-user, and region:

Regulatory Affairs Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

• Regulatory Consulting
• Legal Representation
• Regulatory Writing & Publishing
• Product Registration & Clinical Trial Applications
• Other Services

Regulatory Affairs Outsourcing Company Size Outlook (Revenue, USD Million, 2016 - 2028)

• Small
• Medium
• Large

Regulatory Affairs Outsourcing Category Outlook (Revenue, USD Million, 2016 - 2028)

• Drugs
  • Generics
  • Innovators
• Biologics
  • Biotech
  • ATMPs
  • Biosimilars
• Medical devices
  • Therapeutic
  • Diagnostic

Regulatory Affairs Outsourcing Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

Regulatory Affairs Outsourcing Stage Outlook (Revenue, USD Million, 2016 - 2028)

• Preclinical
• Clinical
• PMA (Post Market Authorization)

Regulatory Affairs Outsourcing End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies

Regulatory Affairs Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
  • Netherlands
  • Switzerland
  • Sweden
  • Azerbaijan
  • Belarus
  • Kazakhstan
  • Moldova
  • Georgia
  • Ukraine
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
  • Armenia
  • Kyrgyzstan
  • Tajikistan
  • Uzbekistan
  • Turkmenistan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Regulatory Affairs Outsourcing Market

• Accell Clinical Research, LLC
• Genpact Ltd.
• Criterium, Inc.
• PRA Health Sciences
• Promedica International
• Medpace
• Charles River Laboratories International, Inc.
• ICON plc
• Covance
• Parexel International Corporation, Inc.
• Freyr

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next Generation Sequencing Market Size Is Predicted To Reach A Valuation Of $11.7 Billion By 2028

 

Next Generation Sequencing Market Growth & Trends

The global next generation sequencing market size is anticipated to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.

Simplification in the NGS workflow coupled with the continued price reductions in instruments as well as reagents is attributed to the increasing adoption of this technology. The cost of sequencing the human genome has reduced from USD 100 million to less than USD 1,000 in less than two decades. Moreover, enhancement in the bioinformatics capabilities will lead to broadening of NGS adoption at the low- and high-throughput ends of the research market.

Several companies are engaged in the innovation of long-read sequencing technologies, which will augment the research as well as clinical application sets. The growing automation in the pre- & post-sequencing protocols, and data analysis is also driving the market. The utilization of novel platforms for the development of personalized medicine at a genetic level is also a significant factor, which is expected to boost the demand for NGS over the forecast period.

Request a free sample copy or view report summary: Next Generation Sequencing Market Report

Next Generation Sequencing Market Report Highlights

• The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology
• Companies like Myriad Genetics, Inc., through its myRisk product, offer genetic testing to identify people who may be at a higher risk of developing certain cancers in the future
• The high utility of NGS technology in the identification of coronavirus strains is expected to drive the infectious diseases segment with the fastest CAGR from 2021 to 2028
• Sequencing was the largest revenue-generating workflow segment in 2020 due to the introduction of novel, portable sequencers as a result of high competition
• In addition, owing to the expected increase in adoption and usage of WGS, sequencing is expected to witness the fastest CAGR over the forecast period
• The clinical research end-use segment is expected to register the fastest CAGR from 2021 to 2028. An increase in the utility of NGS technology and the support of key players for Covid-19 research is responsible for the segment growth
• For instance, in January 2021, to support the Covid-19 surveillance and research, Thermo Fisher Scientific extended its SARS-CoV-2 GlobalAccess Sequencing Program to offer additional units of Ion GeneStudio S5 sequencer and Ion Torrent Genexus System at a subsidized rate
• North America was the largest regional market owing to significant developments in the fields of companion diagnostics, personalized medicine, and NGS
• Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to the expansion of the molecular diagnostics field and high investments by global and local players in the Asian countries
• For instance, in January 2021, Crown Bioscience, Inc.; a U.S.-based platform technology innovator; launched NGS panel services at its Center of Translational Science in Suzhou, China

Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global next generation sequencing market on the basis of technology, application, workflow, end-use, and region:

NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• Reproductive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
  • Newborn Genetic Screening
  • Single Gene Analysis
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

 NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
  • Clonal Amplification
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Next Generation Sequencing Market

• Illumina
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacovigilance Market Set to Record Exponential Growth by 2028

 

Pharmacovigilance Market Growth & Trends

The global pharmacovigilance market size is expected to reach USD 14.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. The increasing incidence of Adverse Drug Reactions (ADR) is the key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.

According to the World Health Organization's (WHO) report on pharmaceutical consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital setups. Hence, there has been a significant rise in the number of medicines made available to healthcare consumers. The rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV services to reduce costs and minimize operational expenses. This is anticipated to serve as an opportunity for contact research organizations in developing regions to gain more revenue share. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services. Companies are also adopting strategies including new product launches and mergers & acquisitions to gain a competitive advantage. Moreover, they are undertaking collaborations with the PV service providers to gain access to medical information and manage PV workflows. For instance, in September 2019, Accenture collaborated with Bayer to implement the company's INTIENT Clinical platform to simplify and speed up its drug development processes, thereby widening its business. The company collaborated with BioCelebrate in 2017 to develop a platform for aggregating and analyzing clinical information for improved drug development efficiency, thus enhancing its R&D capabilities. Such initiatives help companies maintain their market position.

Request a free sample copy or view report summary: Pharmacovigilance Market Report

Pharmacovigilance Market Report Highlights

• By product life cycle, phase IV held a dominant share of 75.61% in 2020 owing to the extensive post-marketing surveillance of pharmaceuticals and an increasing number of ADR incidences in the market
• In terms of service provider, contract outsourcing held a significant share of 59.24% as of 2020 owing to the shift in the focus of pharmaceutical companies to outsourcing services to reduce operational cost
• Based on type, spontaneous reporting held the largest revenue share in 2020 due to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison
• On the basis of end-use, the biotechnology companies segment is anticipated to exhibit a lucrative CAGR of 12.6% over the forecast period owing to the increasing R&D for the development of novel biologics
• Asia Pacific is anticipated to exhibit a lucrative CAGR of 13.2% in the forthcoming years. This is attributed to the availability of low-cost labor and the rising number of outsourcing companies in this region

Pharmacovigilance Market Segmentation

Grand View Research has segmented the global pharmacovigilance market on the basis of the service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2016 - 2028)

• In-house
• Contract Outsourcing

Pharmacovigilance Product Life Cycle Outlook (Revenue, USD Million, 2016 - 2028)

• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV

Pharmacovigilance Type Outlook (Revenue, USD Million, 2016 - 2028)

• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

Pharmacovigilance Process Flow Outlook (Revenue, USD Million, 2016 - 2028)

• Case Data Management
  • Case Logging
  • Case Data Analysis
  • Medical Reviewing & Reporting
• Signal Detection
  • Adverse Event Logging
  • Adverse Event Analysis
  • Adverse Event Review & Reporting
• Risk Management System
  • Risk Evaluation System
  • Risk Mitigation System

Pharmacovigilance Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

Pharmacovigilance End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers
• Others

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa
  • Kingdom of Saudi Arabia

List of Key Players of Pharmacovigilance Market

• Accenture
• Linical Accelovance
• IQVIA
• Cognizant
• Laboratory Corporation of America Holdings
• IBM Corporation
• ArisGlobal
• ICON Plc.
• Capgemini
• ITClinical
• TAKE Solutions
• PAREXEL International Corporation
• BioClinica, Inc.
• Wipro Limited
• UNITED BIOSOURCE CORPORATION
• FMD K&L

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point Of Care Diagnostics & Testing Market is Anticipated to Upgrade USD 35.74 Billion Revenue By 2028

 Point Of Care Diagnostics & Testing Market Growth & Trends

The global point of care diagnostics & testing market size is estimated to reach USD 35.74 billion by 2028, registering a CAGR of 3.25%, according to a new report by Grand View Research, Inc. Point of care (POC) diagnostics & testing has significantly altered the therapeutic models applied for the treatment of diabetic patients, HIV patients, and patients with Cardiovascular Disorders (CVDs), in recent years. In addition, emerging advancements on the horizon are projected to enhance the near-patient treatment workflows for infectious diseases, strokes, and cancer.

The industry is set to witness lucrative growth as POC testing serves as a profitable alternative to traditional laboratory tests. Point-of-care devices are designed to offer actionable information at the location and time of patient care, which enables early diagnosis of diseases. The advent of non-invasive & minimally invasive POC devices, continuous POCT, miniaturized technologies, and the adoption of telemedicine in remote patient monitoring are some of the key trends contributing to the market growth.

Moreover, the advent of rapid data sharing solutions as well as platforms is set to contribute to the development of POC COVID-19 tests, supplementing the overall market growth. Companies actively working toward the development of such rapid data sharing solutions include Foundation for Innovative New Diagnostics (FIND) and 360 Dx. The rising number of such companies is set to offer manufacturers/developers and professionals a clear perspective with respect to the future opportunities associated with POC COVID-19 tests.

The development of multiplex POC diagnostic technologies that enable the detection of multiple infectious pathogens in specimens, such as sputum, urine, or blood, offers improved patient outcomes and better disease diagnosis. The wide adoption of multiplex POC devices is anticipated to serve as a driver for the shift in preference from a centralized disease testing model to a decentralized patient-centered model.

Major companies are initiating strategic product launches to strengthen their market presence. For instance, in October 2020, Roche announced the launch of the Elecsys SARS-CoV-2 Antigen test that supports COVID-19 testing of suspected patients at high volumes. In April 2020, Nova Biomedical introduced PT/INR testing for its Allegro capillary blood analyzer to be used in POC primary care settings. This test is available in CE-regulated countries.

PR/INR is among the total 18 tests of the Allegro platform and is designed to measure HbA1c, hemoglobin, cholesterol, glucose, triglycerides, UACR, creatinine, hematocrit, and uric acid. This product expanded the testing portfolio of the company’s Allergo platform.

Request a free sample copy or view report summary: Point Of Care Diagnostics & Testing Market Report

Point of Care Diagnostics & Testing Market Report Highlights

• The glucose testing product segment led the market in 2020 due to high demand for POC glucose monitors for routine glucose testing as a result of an increased number of diabetic patients across the globe
• The infectious disease product segment is expected to account for the highest revenue share by 2028. This growth is majorly attributed to the global COVID-19 pandemic
• The first POC diagnostic test for COVID-19 was approved by the U.S. FDA in March 2020 under Emergency Use Authorization, which was manufactured by Cepheid
• Since then, key players in this market are engaged in developing and manufacturing such tests, which, in turn, is boosting the segment growth
• The clinics end-use segment accounted for the dominant revenue share in 2020 and will expand further at a steady CAGR from 2021 to 2028 owing to increasing transition from conventional lab testing to POCT by healthcare professionals to shorten the time taken for diagnosis and further treatments
• Led by the U.S., North America was the leading regional market in 2020 and held a revenue share of more than 34%

Point Of Care Diagnostics & Testing Market Segmentation

Grand View Research has segmented the global point of care diagnostics & testing market on the basis of product, end-use, and region:

POC Diagnostics & Testing Product Outlook (Revenue, USD Million, 2017 - 2028)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
  • HIV
  • Clostridium Difficile
  • HBV
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • HPV
  • Influenza/Flu
  • HCV
  • MRSA
  • TB and Drug-Resistant TB
  • HSV
  • COVID-19
  • Other Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

POC Diagnostics & Testing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Clinics
  • Pharmacy & Retail Clinics
  • Physician Office
  • Urgent Care Clinics
  • Non-practice Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

POC Diagnostics & Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of POC Diagnostics & Testing Market

• Hoffmann-La Roche Ltd.
• Qiagen
• Danaher Corp.
• Becton Dickinson (BD)
• Biomerieux SA
• Abbott Laboratories
• Siemens Healthcare AG
• Zoetis, Inc.
• Instrumentation Laboratory
• Nova Biomedical
• Trividia Health, Inc.
• Quidel Corp.
• Trinity Biotech
• Sekisui Diagnostics
• Orasure Technologies, Inc.
• Nipro Corp.
• Spectral Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microscope Market Size Is Expected To Reach USD 16.2 Billion by 2027

 Microscope Market Growth & Trends

The global microscope market size is expected to reach USD 16.2 billion by 2027, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2027. Growing demand for advanced and high resolution or super resolution medical instruments for conducting R&D exercises in the fields of life sciences and nanotechnology is also expected to have a positive impact on demand over the forecast period.

Emergence of new application areas such as quantum dots and miniature transistor chips will serve this market as future growth opportunities. Quantum dots technology is currently in a nascent stage and is expected to cater to multiple application areas such as in transistors, diode lasers, quantum computing, biological imaging, solid-state lighting, electroluminescent displays and photo-voltaic cells. Optical microscopes dominated the market in 2020, primarily owing to their large application base.

However, due to rising adoption rates of advanced medical instruments, scanning probe microscopes (SPMs) and electron microscopes are expected to gain significant revenue share over the next six years. SPM is expected to be the fastest growing product segment, at an estimated CAGR of 9.3% from 2021 to 2027. Features such as non-dependence on wavelength of the source light, resolving atoms and generating better 3D maps of surfaces are some of the factors expected to increase market penetration for these products.

North America is anticipated to witness significant revenue share over the forecast period. This is attributed to presence of advanced healthcare infrastructure, advanced academic institutes, and research and development centers in the region. In addition, presence of significant number of key market players is also contributing to market growth in the region.

Request a free sample copy or view report summary: Microscope Market Report

Microscope Market Report Highlights

• Asia Pacific dominated the market in terms of revenue share in 2020. Evolving demand for semiconductors and positive outlook on application markets is expected to be a key driver for the market in the region
• The life science segment dominated the market and accounted for the largest revenue share in 2020
• Nanotechnology is expected to be the fastest growing application segment at a CAGR of 11.4% from 2021 to 2027
• The optical microscopes segment dominated the market in 2020 owing to a large application scope

Microscope Market Segmentation

Grand View Research has segmented the global microscope market based on product, application, and region:

Microscope Product Outlook (Revenue, USD Million, 2016 - 2027)

• Optical microscopes
  • Upright
  • Inverted
  • Stereomicroscopes
  • Phase Contrast
  • Fluorescence
  • Confocal Scanning
  • Near Field Scanning
  • Others
• Electron microscopes
  • Transmission
  • Scanning Electron
• Scanning probe microscopes
• Others

Microscope Application Outlook (Revenue, USD Million, 2016 - 2027)

• Material Science
• Nanotechnology
• Life Science
• Semiconductors
• Other Applications

Microscope Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Microscope Market

• Carl Zeiss Meditec AG
• Bruker Corporation
• CAMECA
• Thermo Fisher Scientific, Inc.
• Nikon Corporation
• Olympus Corporation
• NT-MDT SI
• Hitachi High-Tech Corporation
• JEOL Ltd.
• Oxford Instruments (Asylum Corporation)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Roll-Your-Own Tobacco Product Market Estimated To Flourish By 2028: Grand View Research Inc.

 Roll-Your-Own Tobacco Product Market Growth & Trends

The global roll-your-own tobacco product market size is expected to reach USD 10.42 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.2% from 2021 to 2028. The rising consumption of products among females and students is fueling market growth over the world. The adoption rate of the product is increasing among the youth in major economies, including the U.S. Moreover, the financial stress caused by the COVID-19 pandemic has encouraged numerous smokers to shift from factory-made cigarettes to hand-rolled cigarettes due to the cost advantage of roll-your-own (RYO) tobacco products.

The filter and paper tip segment is expected to register the fastest CAGR of 4.7% from 2021 to 2028. Rapid research and product development of new kinds of filters focusing on removing maximum tar, nicotine, and certain gases are estimated to fuel the segment growth. Furthermore, the introduction of biodegradable or environment-friendly filters is expected to boost the demand for filter and paper tips in the upcoming years.

Europe dominated the market with a revenue share of more than 55.0% in 2020. According to the World Health Organization (WHO), Europe reported the highest prevalence of smoking among adults (28%), with a percentage of the consumption trend observed among adolescents. Cigarettes witnessed the highest consumption among Europeans. The popularity of RYO cigarettes is on the rise among consumers due to the cost-effectiveness of the products and the availability of varied flavors. The consumption of RYO cigarettes in the region is mainly concentrated among men who smoke regularly.

Companies are looking to maintain their brand image and gain customer loyalty by upgrading their offerings according to customer specifications and studying consumer behavior patterns. Key players in the market are offering tobacco products in different sizes, flavors, and attractive packaging. These initiatives by manufacturers are propelling the global demand for premium roll-your-own tobacco products.

Request a free sample copy or view report summary: Roll-Your-Own Tobacco Product Market Report

Roll-Your-Own Tobacco Product Market Report Highlights

• North America is expected to register the fastest CAGR of 4.7% from 2021 to 2028 owing to the increasing adoption of the product among the young consumers
• By product, the filter and paper tip segment is expected to register the fastest CAGR of 4.7% from 2021 to 2028
• Europe dominated the market by accounting for over 55.0% in 2020. The rate of smoking in the European countries has contributed to the growth of the market in the region
• Offline distribution channel held the largest share of more than 85.0% in 2020

Roll-Your-Own Tobacco Product Market Segmentation

Grand View Research has segmented the global roll-your-own tobacco product market on the basis of products, distribution channel, and region:

RYO Tobacco Products Outlook (Revenue, USD Million, 2016 - 2028)

• RYO Tobacco
• Rolling Paper & Cigarette Tubes
• Injector
• Filter & Paper Tip

RYO Tobacco Product Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Offline
• Online

RYO Tobacco Product Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Roll-Your-Own Tobacco Product Market

• Imperial Brands
• British American Tobacco
• Japan Tobacco International
• Scandinavian Tobacco Group A/S
• Altria Group, Inc.
• Philip Morris International
• HBI International
• Curved Papers, Inc.
• Karma Filter Tips
• Shine Brands

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Honey Market to Reflect a Holistic Expansion During 2021 to 2028: Grand View Research Inc.

 Honey Market Growth & Trends

The global honey market size is expected to reach USD 17.34 billion by 2028 registering a CAGR of 8.2%, according to a new report by Grand View Research, Inc. Rising awareness about maintaining a healthy lifestyle is expected to be the key driver for the market growth over the forecast period. Honey has excellent nutritional and medicinal properties. It improves body immunity, helps in weight management, and prevents blood pressure issues. It is also a rich source of antioxidants and helps in healing burn wounds and scars. Due to such properties, it is widely used in various sectors apart from food & beverages, such as personal care & cosmetics and pharmaceuticals.

Europe was the largest regional market in 2020 and accounted for a revenue share of more than 34.0% in 2020. In January 2018, Altıparmak, a leading honey producer of Turkey, got funding from the European Bank for Reconstruction and Development (EBRD) of USD 4.98 million to develop and advance its value chain. Moreover, it is also used for the improvement of its production and innovation in Apitherapy.

Request a free sample copy or view report summary: Honey Market Report

Honey Market Report Highlights

• The food & beverages application segment was the largest product segment in 2020 and accounted for a share of more than 70%
• However, the personal care & cosmetics application segment is estimated to register the fastest CAGR from 2021 to 2028
• The supermarket/hypermarket distribution channel segment led the market in 2020 and will retain its dominant position throughout the forecast period due to the increasing number of new stores across the globe
• The online segment is expected to register the fastest CAGR of over 8% from 2021 to 2028. The recent global pandemic has forced customers to start shopping through e-commerce, which, in turn, drives the segment growth
• Asia Pacific is expected to remain the fastest-growing regional market over the forecast period on account of the expansion of the food & beverage sector in countries including China, India, and Japan

Honey Market Segmentation

Grand View Research has segmented the global honey market on the basis of application, distribution channel, and region:

Honey Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2028)

• Food & Beverages
• Personal Care & Cosmetics
• Pharmaceutical

Honey Distribution Channel Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2028)

• Convenience Stores
• Supermarket/Hypermarket
• Online

Honey Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
• Central & South America
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Honey Market

• Beeyond the Hive
• Dabur India Ltd.
• Patanjali Ayurved
• Capilano Honey Ltd.
• Barkman Honey, LLC.
• New Zealand Honey Co.
• Oha Honey LP
• Bee Maid Honey Ltd.
• Streamland Biological Technology Ltd.
• Dutch Gold Honey, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Reusable Water Bottle Market Top Players ,Analysis And Forecast Till 2028: Grand View Research Inc.

 Reusable Water Bottle Market Growth & Trends

The global reusable water bottle market size is expected to reach USD 84.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.0% from 2021 to 2028. Government regulations and the anti-plastic movement are encouraging consumers to switch to disposable water bottles and prompting manufacturers to develop environmentally-friendly products. Furthermore, the extensive use of disposable water bottles in sports and public places is discouraged by various campaigns in order to create awareness among people. Some governments have taken initiatives for the same, for instance, in February 2019, UNICEF and the Ministry of Education Maldives decided to provide reusable water bottles to all the first graders in the Maldives.

According to Forbes Media LLC, every minute humans buy a million plastic bottles and the fact that 91% of this plastic is not recycled is becoming a threat to the environment. However, the growing demand for environmentally-friendly products and easy-to-carry bottles among consumers is a major factor fueling the market growth.

Metal-based reusable water bottles are gaining increasing traction among consumers. Since water packed in plastic bottles for long durations under various conditions dissolves harmful chemicals from the bottle surface, and thereby does not meet the safe drinking water standards and is unfit and unhealthy for consumption. In such cases, RO and UV filtered municipal water if filled in a reusable bottle, is a healthier alternative, thereby driving the demand for such reusable water bottles.

Therefore, health advantages associated with metal-based bottles, such as restraining harmful chemicals emitted from plastic bottles, are causing greater adoption of the product among consumers. In addition, the multi-purpose usage of stainless-steel water bottles in keeping water cold or hot for longer durations owing to their insulating properties has attracted consumers to these products.

Increasing preference of the younger population for buying various products through specialty stores owing to greater quality, fewer chances of selling counterfeit products, and assistance in buying the products is a key factor boosting the growth of the specialty stores segment.

The majority of the countries in the Asia Pacific market are the ones that consider the price of the product first, hence are said to be cost centric. Consumers can significantly save up to 2,000 times the expenditure on water bottles by preferring reusable water bottles. This factor is supporting the demand for reusable water bottles in the region. The growing trend of refilling water bottles in the region is boosting the demand for reusable water bottles. For instance, Social Innovation Japan launched MyMizu, the first free water refill app, with an aim to reduce PET bottle consumption in Japan. This app connects users to 8,000+ refill stations nationwide. These factors are boosting the demand for reusable water bottles among consumers.

Request a free sample copy or view report summary: Reusable Water Bottle Market Report

Reusable Water Bottle Market Report Highlights

• Based on material, plastic is expected to register the highest CAGR over the forecast period
• By distribution channel, supermarkets and hypermarkets accounted for the largest share of 38.4% in 2020
• The online distribution channel segment is expected to expand at the highest CAGR of 4.9% from 2021 to 2028 due to the rising penetration of e-commerce and the low cost of startups
• The Asia Pacific held the largest share of 39.2% in 2020

Reusable Water Bottle Market Segmentation

Grand View Research has segmented the global reusable water bottle market on the basis of material type, distribution channel, and region:

Reusable Water Bottle Material Type Outlook (Revenue, USD Million, 2016 - 2028)

• Glass
• Stainless Steel
• Plastic
• Silicone
• Others

Reusable Water Bottle Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Specialty Stores
• Convenience Stores
• Supermarkets & Hypermarkets
• Online

Reusable Water Bottle Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
• Central & South America
• Middle East & Africa

List of Key Players of Reusable Water Bottle Market

• Tupperware Brands Corporation
• SIGG Switzerland AG, GmbH
• Contigo
• CAMELBAK PRODUCTS LLC
• Nalge Nunc International Corp.
• Klean Kanteen Inc.
• Hydaway
• Aquasana, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Home Bedding Market Report by Opportunity, Demand, Major Driving Factors and Business Growth Strategies

 Home Bedding Market Growth & Trends

The global home bedding market size is expected to reach USD 147.09 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.0% from 2021 to 2028. The market is driven by the increasing consumer preference for adjustable beds, which has progressed in the lockdown caused by Covid-19 as an aid to suitably adjust the work-from-home culture. This trend has risen the penetration of customizable mattresses and bed linens, thereby boosting the market growth. Higher residential growth across regions indicating rising housing construction as well as housing permits is bound to revamp the market demand.

According to the Federal Statistical Office (Destatis), the construction of a total of 32,500 dwellings was permitted in Germany in November 2020. Compared with the corresponding period of 2019, this is an increase of 8.9% or 2,700 dwellings. However, the industry also faces significant instances of uncertainties projected by the International Sleep Products Association in 2018. For instance, the U.S. mattress industry has been affected by international trade. While imports of finished mattresses have continued to surge, their long-term significance is complicated by both higher tariffs on finished mattresses and many components, and a pending antidumping investigation on mattresses from China.

Increased consumer inclination towards working from their homes and beds has caused intermittent growth for premium and quality bedding products. According to Jerry Epperson, a mattress industry veteran and managing director of investment banking and corporate advisory firm Mann, Armistead & Epperson based in Virginia, the bedding industry enjoyed a year-over-year sales increase of more than 30% in October 2020. Moreover, the industry is benefiting from new innovations, such as high-tech adjustable bases, and interest in ancillary products sold, such as luxury pillows.

Higher traction towards designed bedrooms is linked to period dramas and active series on the OTT platforms wherein a large chunk of consumers is engaged as a cause of higher time spent indoors. One such period drama influencing a majority of consumers is Netflix’s period drama Bridgerton. It turns out that the hit series has inspired many of us to add a touch of Regency-era decor into homes. Bridgerton bedrooms alone have gained increased popularity, with an 81% increase in Google search since the show aired, according to a blog by Real Homes as of 17^th January 2021. This trend has influenced consumers to adopt layering as adding a mixture of different textures and tones into a bedroom by using cushions, bedsheets, and throws is a simple way to build a luxurious feel. This scenario is likely to offer growth opportunities for the market.

Bed linens held the largest share of 31.6% in 2020. This dominance is primarily due to the increasing consumer preference for quality over brands. This has encouraged manufacturers to offer new and improved quality products with attractive designs. With the increasing preference for superior quality products, companies are focusing on introducing plant-based bed linen that claims to be softer than cotton and provides breathability and moisture control.

Request a free sample copy or view report summary: Home Bedding Market Report

Home Bedding Market Report Highlights

• Asia Pacific is expected to register the fastest CAGR from 2021 to 2028. The regional demand for home bedding products is anticipated to grow due to the increase in the purchasing power of consumers, rising housing constructions, and growing consumer awareness regarding quality as well as sustainable bedding products
• The offline distribution channel segment dominated the market by accounting for 68.9% share in 2020
• By type, the bed linen segment held the largest share of 31.6% in 2020 owing to its higher penetration across households

Home Bedding Market Segmentation

Grand View Research has segmented the global home bedding market on the basis of type, distribution channel, and region:

Home Bedding Type Outlook (Revenue, USD Million, 2016 - 2028)

• Mattress
• Bed Linen
• Pillows
• Blankets
• Others

Home Bedding Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Offline
• Online

Home Bedding Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Home Bedding Market

• Acton & Acton Ltd.
• American Textile Company
• Beaumont & Brown Ltd
• Boll & Branch LLC
• WestPoint
• Pacific Coast Feather Company
• Hollander
• Portico Inc.
• Crane & Canopy
• Bombay Dyeing

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Maintenance, Repair & Overhaul Distribution Market Set to Witness an Uptick during 2021 to 2028

 North America MRO Distribution Market Growth & Trends

The North America maintenance, repair & overhaul distribution market size is expected to reach USD 178.85 billion by 2028 registering a CAGR of 2.9%, according to a new report by Grand View Research, Inc. Increasing product penetration in the manufacturing industry on account of standardization of critical services and equipment is expected to drive the market growth. Moreover, increasing product demand from other end-use industries is also likely to support market growth. The periodic maintenance, repair, and overhaul (MRO) activities help reduce overall costs and enhance the productivity of the industrial operations, which is expected to drive their demand.

The MRO distribution or supply chain was traditionally considered an indirect component of the industrial operations. The lack of focus and investments in MRO processes in the past resulted in the slow growth of the industry. However, the recent global pandemic has contributed to raising awareness regarding crisis management of the supply chain in the manufacturing industry, which is expected to benefit the market growth. The value chain of this market includes manufacturers, specialists, generalists, partnerships, integrated supply, and retailers. Manufacturers play a major role across the value chain, by possessing definitive control over the market as they monitor the product pricing. They usually command pricing on a customer-by-customer basis rather than on a distributor-by-distributor basis.

Request a free sample copy or view report summary: North America Maintenance, Repair & Overhaul Distribution Market Report

North America MRO Distribution Market Report Highlights

• Power transmission-pneumatics are expected to witness the fastest growth from 2021 to 2028 on account of the rising utilization of automated transmission in manufacturing facilities
• The food, beverage, & tobacco end-use industry accounted for a revenue share of 13.24% in 2020 owing to the increased focus of key companies on improvements in machine capabilities for enhanced food production
• Minnesota and Missouri were the major contributors to the region’s overall product demand owing to increased investments in the manufacturing and transportation sectors
• The manufacturing sector in Canada is anticipated to witness the fastest growth as the majority of the manufacturers are planning to invest in new equipment and machinery to gain a competitive advantage
• Moreover, manufacturers are trying to expand their customer reach through e-commerce platforms to access a wide range of categories, with significant expertise in the industry

North America MRO Distribution Market Segmentation

Grand View Research has segmented the North America maintenance, repair & overhaul distribution market on the basis of product, end use, and region:

North America MRO Distribution Product Outlook (Revenue, USD Million, 2017 - 2028)

• Abrasives
• Chemicals
• Cutting Tools
• Fasteners
• Hand Tools
• Pipes, Valves & Fitting
• Power Tools
• Power Transmission - Hydraulics
• Power Transmission - Pneumatics
• Power Transmission - Electrics
• Rubber Products
• Seal
• Welding Equipment & Gases
• Automation
• Others

North America MRO Distribution End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Food, Beverage, & Tobacco
• Textile
• Wood & Paper
• Mining, Oil, & Gas
• Metal Processing & Foundry
• Rubber, Plastic & Non-Metallic
• Chemicals
• Pharmaceuticals
• Electrical & Electronics
• Transportation
• Construction
• Others

North America MRO Distribution Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
    • New England
    • Mid Atlantic
    • East North Central
    • West North Central
    • South Atlantic
    • East South Central
    • West South Central
    • West Region
  • Canada

List of Key Players of North America MRO Distribution Market

• Hillman Group, Inc.
• Wajax Industrial Components
• FCX Performance
• SBP Holdings
• R.S. Hughes Co., Inc.
• DGI Supply
• Lawson Products, Inc.
• AWC
• Hisco, Inc.
• Kimball Midwest
• Bisco Industries
• Kaydon Corporation
• BDI

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.